Compare HALO & OR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | OR |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.9B |
| IPO Year | N/A | N/A |
| Metric | HALO | OR |
|---|---|---|
| Price | $68.77 | $37.59 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 4 |
| Target Price | ★ $73.33 | $36.25 |
| AVG Volume (30 Days) | ★ 2.3M | 1.2M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.56% |
| EPS Growth | ★ 56.68 | N/A |
| EPS | ★ 4.74 | 0.78 |
| Revenue | ★ $1,242,852,000.00 | $243,647,000.00 |
| Revenue This Year | $34.83 | $89.31 |
| Revenue Next Year | $24.84 | $31.35 |
| P/E Ratio | ★ $14.54 | $47.14 |
| Revenue Growth | 31.19 | ★ 33.28 |
| 52 Week Low | $47.00 | $17.55 |
| 52 Week High | $79.50 | $42.25 |
| Indicator | HALO | OR |
|---|---|---|
| Relative Strength Index (RSI) | 58.75 | 66.34 |
| Support Level | $61.23 | $36.53 |
| Resistance Level | $69.28 | $37.82 |
| Average True Range (ATR) | 1.69 | 1.21 |
| MACD | 0.69 | 0.24 |
| Stochastic Oscillator | 93.54 | 89.98 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
OR Royalties Inc, formerly Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.